NHS National Generic Pharmaceuticals Interim 2 2020
Offer reference number: CM/PHG/20/5619
Period of framework agreement: 12 months with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 36 months. The total maximum duration of the framework agreement to be no more than 48 months
Potential periods of call-offs under the framework agreement:
Hospital only products – All regions: 01/02/2021 to 31/01/2022
Orals (plus non-parenterals) – All regions: 01/03/2021 to 28/02/2022